DiaMedica Therapeutics Inc. Operating Lease Liability
DiaMedica Therapeutics Inc. (DMAC) had Operating Lease Liability of $176.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability $176.00K.
- 2026-03-31: Operating Lease, Liability $200.00K.
- 2025-12-31: Operating Lease, Liability $225.00K.
- 2025-09-30: Operating Lease, Liability $249.00K.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2026-06-30 | $176.00K 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $200.00K 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $225.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $249.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $272.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $294.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $315.00K 10-K · filed 2025-03-17 | |
| 2024-09-30 | $337.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $357.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $377.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $396.00K 10-K · filed 2024-03-19 | |
| 2023-09-30 | $415.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $433.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $450.00K 10-Q · filed 2023-05-15 | |
| 2022-09-30 | $459.00K 10-K · filed 2023-03-28 | $449.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $11.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $28.00K 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $45.00K 10-K · filed 2022-03-14 | |
| 2021-09-30 | $60.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $75.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $91.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $105.00K 10-K · filed 2021-03-10 | |
| 2020-09-30 | $120.00K 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $132.00K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $146.00K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $159.00K 10-K · filed 2020-03-23 | |
| 2019-09-30 | $171.00K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $183.00K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $195.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |